Last reviewed · How we verify
anti-diabetic herbal drug
anti-diabetic herbal drug is a Small molecule drug developed by Kerman Medical University. It is currently FDA-approved for Type 2 diabetes mellitus. Also known as: NOSHIN SHAHD drug.
An herbal formulation that improves blood glucose control through multiple plant-derived bioactive compounds with insulin-sensitizing and glucose-regulating properties.
An herbal formulation that improves blood glucose control through multiple plant-derived bioactive compounds with insulin-sensitizing and glucose-regulating properties. Used for Type 2 diabetes mellitus.
At a glance
| Generic name | anti-diabetic herbal drug |
|---|---|
| Also known as | NOSHIN SHAHD drug |
| Sponsor | Kerman Medical University |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | FDA-approved |
Mechanism of action
Herbal anti-diabetic drugs typically contain polyphenols, alkaloids, and other phytochemicals that enhance insulin secretion, improve insulin sensitivity, reduce hepatic glucose production, or slow intestinal glucose absorption. The specific mechanism depends on the constituent herbs, which may include plants traditionally used in Persian/Iranian medicine for metabolic regulation.
Approved indications
- Type 2 diabetes mellitus
Common side effects
Key clinical trials
- Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation (PHASE3)
- Effect of Golden Rice-Piper Crocatum Cookies on Neuropathy Prevention in Diabetes (NA)
- Efficacy of NOSHINtrial in Diabetic Patients (PHASE4)
- Berberine as Adjuvant Treatment for Schizophrenia Patients (PHASE2, PHASE3)
- Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition (PHASE1)
- Effect of Apple Cider Vinegar and Metformin Combination vs Metformin Alone in Type 2 Diabetics (NA)
- Anti-Diabetic Effect of Gynostemma Pentaphyllum Tea as add-on Therapy With Sulfonylureas in Type 2 Diabetic Patients (PHASE1, PHASE2)
- Anti-diabetic Effect of Gynostemma Pentaphyllum Tea in Type 2 Diabetic Patients (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- anti-diabetic herbal drug CI brief — competitive landscape report
- anti-diabetic herbal drug updates RSS · CI watch RSS
- Kerman Medical University portfolio CI
Frequently asked questions about anti-diabetic herbal drug
What is anti-diabetic herbal drug?
How does anti-diabetic herbal drug work?
What is anti-diabetic herbal drug used for?
Who makes anti-diabetic herbal drug?
Is anti-diabetic herbal drug also known as anything else?
What development phase is anti-diabetic herbal drug in?
Related
- Manufacturer: Kerman Medical University — full pipeline
- Therapeutic area: All drugs in Diabetes
- Indication: Drugs for Type 2 diabetes mellitus
- Also known as: NOSHIN SHAHD drug
- Compare: anti-diabetic herbal drug vs similar drugs
- Pricing: anti-diabetic herbal drug cost, discount & access